Kyntra Bio Inc (KYNB)

Apr 14, 2026

Kyntra Bio (KYNB) Upgraded to Buy: Here's What You Should Know - Yahoo Finance

Apr 14, 2026

Apr 12, 2026

What date does Kyntra Bio Inc's (KYNB) report EarningsEarnings Calendar & Announcement - Zacks Investment Research

Apr 12, 2026

Apr 10, 2026

Kyntra Bio, Inc. Files 8-K Current Report with SEC – Company Information, Address, and NASDAQ Listing Details - Minichart

Apr 10, 2026

Apr 09, 2026

Kyntra Bio Faces Nasdaq Compliance Challenge After Revenue Shift - TipRanks

Apr 09, 2026

Apr 09, 2026

Kyntra Bio Disclosed Failure to Satisfy a Continued Listing Rule or Standard - TradingView — Track All Markets

Apr 09, 2026

Apr 09, 2026

Nasdaq warns Kyntra Bio (NASDAQ: FGEN) over Global Select listing test - Stock Titan

Apr 09, 2026

Apr 09, 2026

KYNB Stock Price, Quote & Chart | KYNTRA BIO INC (NASDAQ:KYNB) - ChartMill

Apr 09, 2026

Apr 08, 2026

Kyntra Bio to Present at the 25th Annual Needham Virtual Healthcare Conference - Bitget

Apr 08, 2026

Apr 04, 2026

KYNB PE Ratio & Valuation, Is KYNB Overvalued - Intellectia AI

Apr 04, 2026

Mar 31, 2026

FGEN SEC FilingsFibrogen Inc 10-K, 10-Q, 8-K Forms - Stock Titan

Mar 31, 2026

Mar 28, 2026

Kyntra Bio (MEX:KYNB) PB Ratio : (As of Mar. 28, 2026) - GuruFocus

Mar 28, 2026

Mar 27, 2026

Kyntra Bio, Inc.Common Stock (NQ: KYNB - FinancialContent

Mar 27, 2026

Mar 25, 2026

KYNB Technical Analysis | Trend, Signals & Chart Patterns | KYNTRA BIO INC (NASDAQ:KYNB) - ChartMill

Mar 25, 2026

Mar 22, 2026

If You Invested $1,000 in Fibrogen Inc (FGEN) - Stock Titan

Mar 22, 2026

Mar 17, 2026

Advancing Pipeline and 2026 Clinical Catalysts Underpin Buy Rating on Kyntra Bio - tipranks.com

Mar 17, 2026

Mar 17, 2026

Kyntra Bio, Inc. 2023 Annual Report: Business Overview, Risk Factors, and Financial Highlights - Minichart

Mar 17, 2026

Mar 17, 2026

Kyntra Bio Inc (KYNB) Q4 2025 Earnings Call Highlights: Navigating Revenue Decline with ... By GuruFocus - Investing.com Canada

Mar 17, 2026

Mar 16, 2026

Kyntra Bio Inc (KYNB) Q4 2025 Earnings Call Highlights: Navigati - GuruFocus

Mar 16, 2026

Mar 16, 2026

Maintaining a Hold on Kyntra Bio Amid Pipeline Refocus and Pending Clinical Inflection Points - TipRanks

Mar 16, 2026

Mar 16, 2026

Kyntra Bio 2025 Review: Clinical Progress on Cancer Drugs and Future OutlookNews and Statistics - IndexBox

Mar 16, 2026

Mar 16, 2026

KYNB: Cash runway extended to 2028 as FG-3246 and roxadustat advance in key late-stage trials - TradingView

Mar 16, 2026

Mar 16, 2026

Kyntra Bio (KYNB) Fourth Quarter 2025 Earnings Conference Call Transcript - Bitget

Mar 16, 2026

Mar 16, 2026

Kyntra Bio (KYNB) Q4 2025 Earnings Call Transcript - The Globe and Mail

Mar 16, 2026

Mar 16, 2026

Kyntra Bio, Inc. 2025 Q4ResultsEarnings Call Presentation (NASDAQ:KYNB) 2026-03-16 - Seeking Alpha

Mar 16, 2026

Mar 16, 2026

Kyntra Bio: Fourth Quarter Financial Overview - Bitget

Mar 16, 2026

Mar 16, 2026

Kyntra Bio: Q4 Earnings Snapshot - marketscreener.com

Mar 16, 2026

Mar 16, 2026

Kyntra Bio reports $6.44M revenue, $45.37 EPS on divestiture gain - TradingView

Mar 16, 2026

Mar 16, 2026

Kyntra Bio (NASDAQ: KYNB) pivots to oncology and advances FG-3246, roxadustat - Stock Titan

Mar 16, 2026

Mar 16, 2026

Kyntra Bio Reports Fourth Quarter and Full Year 2025 Financial Results and Provides Business Update - The Manila Times

Mar 16, 2026

Mar 16, 2026

KYNB: Revenue fell but net loss improved; clinical and regulatory milestones achieved - TradingView

Mar 16, 2026

Mar 16, 2026

Kyntra Bio (Nasdaq: KYNB) unveils 2025 results, FG-3246 and roxadustat plans - Stock Titan

Mar 16, 2026

Mar 16, 2026

New prostate cancer drug trial advances as Kyntra Bio cuts 2025 loss - Stock Titan

Mar 16, 2026

Mar 15, 2026

FibroGen (KYNB) Set to Announce Q4 Earnings with Significant Dec - gurufocus.com

Mar 15, 2026

Mar 11, 2026

KYNB: Lead oncology and anemia programs advance with strong data, regulatory clarity, and commercial promise - TradingView

Mar 11, 2026

Mar 11, 2026

Kyntra Bio : Corporate Presentation – March 2026 - marketscreener.com

Mar 11, 2026

Mar 10, 2026

Kyntra Bio (KYNB) CEO reports 277-share tax withholding event - Stock Titan

Mar 10, 2026

Mar 10, 2026

Tax withholding slightly trims Kyntra Bio (KYNB) CFO share holdings - Stock Titan

Mar 10, 2026

Mar 10, 2026

Kyntra Bio (KYNB) Stock Analysis Report | Ratings, Financials & Performance - Benzinga Japan

Mar 10, 2026

Mar 09, 2026

Kyntra Bio (KYNB) Expected to Beat Earnings Estimates: What to Know Ahead of Q4 Release - Finviz

Mar 09, 2026

Mar 09, 2026

Kyntra Bio to Report Fourth Quarter and Full Year 2025 Financial Results - Bitget

Mar 09, 2026

Mar 03, 2026

Analysts’ Opinions Are Mixed on These Healthcare Stocks: Kyntra Bio (KYNB), Crispr Therapeutics AG (CRSP) and GoodRx Holdings (GDRX) - The Globe and Mail

Mar 03, 2026

Mar 02, 2026

KYNB Price History for Kyntra Bio Stock - Barchart.com

Mar 02, 2026

Mar 01, 2026

KYNB | Kyntra Bio, Inc. Common Institutional Ownership - Quiver Quantitative

Mar 01, 2026

Feb 24, 2026

Kyntra Bio reports prostate cancer trial results at ASCO GU - Investing.com South Africa

Feb 24, 2026

Feb 24, 2026

What's Going On With Kyntra Bio Stock Tuesday? - Bitget

Feb 24, 2026

Feb 23, 2026

Kyntra Bio announces positive data from Phase 1b/2 study of FG-3246 - TipRanks

Feb 23, 2026

Feb 23, 2026

Kyntra Bio reports prostate cancer trial results at ASCO GU By Investing.com - Investing.com Australia

Feb 23, 2026

Feb 23, 2026

KYNB to Present FG-3246 Trial Data at ASCO GU 2026 - GuruFocus

Feb 23, 2026

Feb 23, 2026

Kyntra Bio Announces Positive Data from the Investigator-Sponsored Phase 1b/2 Study of FG-3246 in Combination with Enzalutamide in Patients with Metastatic Castration Resistant Prostate Cancer to Be Presented at ASCO GU 2026 - marketscreener.com

Feb 23, 2026

Feb 18, 2026

KYNB Stock Price, News & Analysis - Stock Titan

Feb 18, 2026

Feb 17, 2026

Kyntra Bio to Participate in Upcoming Investor Conferences - The Manila Times

Feb 17, 2026

Feb 17, 2026

Why Did Compass Pathways Stock Rocket Higher Today? - AOL.com

Feb 17, 2026